🇺🇸 Ancef In Sodium Chloride 0.9% In Plastic Container in United States

Ancef In Sodium Chloride 0.9% In Plastic Container (Cefazolin Sodium) regulatory status in United States.

Marketing authorisations

FDA

  • Status: approved

FDA

  • Application: NDA050566
  • Marketing authorisation holder: BAXTER HLTHCARE
  • Local brand name: ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

Ancef In Sodium Chloride 0.9% In Plastic Container in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in United States

Frequently asked questions

Is Ancef In Sodium Chloride 0.9% In Plastic Container approved in United States?

Yes. FDA has authorised it; FDA has authorised it.

Who is the marketing authorisation holder for Ancef In Sodium Chloride 0.9% In Plastic Container in United States?

GSK is the originator. The local marketing authorisation holder may differ — check the official source linked above.